Stock 7096 STEMCELL INSTITUTE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News StemCell Institute Inc.

Equities

7096

JP3399640006

Market Closed - Japan Exchange
Other stock markets
 07:00:00 29/05/2024 BST 		5-day change 1st Jan Change
1,649 JPY -2.14% Intraday chart for StemCell Institute Inc. -7.88% -23.09%
2023 Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023. CI
2023 Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023. CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2023.
CI
Certain Common Shares of Cuorips Inc. are subject to a Lock-Up Agreement Ending on 24-SEP-2023.
CI
Cuorips Inc. has completed an IPO in the amount of ¥3.432 billion.
CI
Cuorips Inc. has filed an IPO.
CI
Certain Common Stock of StemCell Institute Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2021.
CI
Certain Common Stock of StemCell Institute Inc. are subject to a Lock-Up Agreement Ending on 22-SEP-2021.
CI
StemCell Institute Inc. has completed an IPO in the amount of ¥2.32624 billion.
CI
StemCell Institute Inc. has filed an IPO.
CI
CUORiPS Inc. announced that it expects to receive ¥2 billion in funding from Asahi Intecc Co., Ltd., StemCell Institute Inc., Dai-Dan Co., Ltd., Taiko Pharmaceutical Co.,Ltd., Kyoto University Innovation Capital Co., Ltd., Terumo Corporation and other investors
CI
StemCell Institute Inc. has withdrawn its IPO.
CI
StemCell Institute Inc. has filed an IPO.
CI
TrimGen Holdings Co., Ltd completed the acquisition of 56.57% stake in StemCell Institute Inc. from Nihon Trim Co., Ltd..
CI
TrimGen Holdings Co., Ltd agreed to acquire 56.57% stake in StemCell Institute Inc. from for Nihon Trim Co., Ltd. approximately ¥940 million.
CI
Nihon Trim Co., Ltd. completed the acquisition of 50.1% stake in Stemcell Institute from Kunimatsu Yamamoto and funds sponsored by Japan Asia Investment Co. Ltd., JAFCO Co., Ltd. and Ant Capital Partners Co., Ltd.
CI
Nihon Trim Co., Ltd. agreed to acquire a 50.1% stake in Stemcell Institute from Kunimatsu Yamamoto and funds sponsored by Japan Asia Investment Co. Ltd., JAFCO Co., Ltd. and Ant Capital Partners Co., Ltd. for approximately ¥790 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 7096 Stock
  4. News StemCell Institute Inc.